Additionally, QKI is associated with the prognosis of diffuse large B-cell lymphoma (DLBCL) (Pan et al., 2021), NSCLC (Li et al., 2021), and leukemia (Tili et al., 2015). The gene discussed is QKI; the disease is non-small cell lung carcinoma.